Dynamic Technology Lab’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29,630
Closed -$84K 891
2025
Q3
$84K Buy
29,630
+10,183
+52% +$34.9K 0.01% 737
2025
Q2
$73K Buy
+19,447
New +$76.5K 0.01% 860
2025
Q1
Sell
-32,845
Closed -$232K 1154
2024
Q4
$232K Buy
+32,845
New +$262K 0.04% 724
2024
Q3
Sell
-63,854
Closed -$408K 1144
2024
Q2
$408K Buy
+63,854
New +$410K 0.05% 585
2024
Q1
Sell
-69,669
Closed -$645K 1205
2023
Q4
$645K Buy
+69,669
New +$569K 0.07% 494
2022
Q3
Sell
-42,697
Closed -$619K 1284
2022
Q2
$619K Buy
+42,697
New +$728K 0.07% 487
2021
Q4
Sell
-16,060
Closed -$803K 1278
2021
Q3
$803K Buy
+16,060
New +$876K 0.1% 337
2020
Q1
Sell
-13,606
Closed -$472K 1168
2019
Q4
$472K Buy
+13,606
New +$450K 0.08% 476

Other funds holding HCAT

Dynamic Technology Lab's HCAT Position: Q4 2025 in Review

Dynamic Technology Lab sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 29,630 shares — an estimated $84K sold.

Dynamic Technology Lab first reported a position in HCAT in Q4 2019 and held it in 8 quarters. The position peaked at $803K in Q3 2021. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Dynamic Technology Lab reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 29,630 Health Catalyst shares in Q4 2025, an estimated $84K.
  • Dynamic Technology Lab first reported a position in Health Catalyst in Q4 2019 and held it in 8 quarters.
  • Dynamic Technology Lab's Health Catalyst position peaked at $803K in Q3 2021.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Dynamic Technology Lab's 13F filing for Q4 2025, filed 13 Feb 2026.